Icon
+91 94997 68112
Login Register

Xigduo XR - (5,10 mg/500mg; 5,10 mg/1000 mg, Tablet, Extended release)

Dapagliflozin; Metformin hydrochloride Astrazeneca
5,10 mg/500mg; 5,10 mg/1000 mg, Tablet, Extended release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate
Yes
** **** ** ****** *** ***** ** ********** *** ******, *** **** *** *****. *** ** **** ** ****** *** **** *** **** ** **** **** *********. *** ******, *** **** *** ***** *** ******** *** *** **** ***********. *** ****** ***** * **** ** ** ******* '***, '***, *** '***, *** *** *********. *** ****** **** ***** * **** *** ** ******* '***, '***, '***, *** '***. *** ******, *** **** *** ***** *** ********* ********. ** ********* ******** ****** ** *****, *** ******** **** **** *** ********** ******* *********** ** ** ******* ** *** *********. ** ***** ** **** *** *********** (*-***) ** *** ****** **** ******** ** *** **,****, ** ****** ******** ****** ***** ****.
Xigduo XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
*** ****** **** *** **** ** *** **, **** **** *** *** ********* *** ********* ****** *** **** *** *** *********
*** **** **** *** **** *** **** *** *** ********* *** ********* *** ********* *** ********* *** *********
***** **** *** **** *** **** *** *** ********* *** ********* *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** \ *** -**- ******* ********* ******** ****** *** **, ****
*** **** *** \ *** -**- *** ********* ********* ******** ** *** **, ****
***** *** \ *** -**- *** ********* ********* ******** ** *** **, ****
  1. *** *, **** : * **** ** ** ***** *** ***** *** *** *** *********.
  2. *** *, **** : *** ****** ***** **** ** ** ******* '***, '***, *** '***, *** *** *********. *** ****** ***** * ***** *** ** ****** '***
  3. *** *, **** : *** **** ***** * **** ** ** ******* '***, '***, '*** *** '***, *** *** *********
  4. *** *, **** : *** ****** *** *** **** ***** * **** *** ** ******* '***, '***, '***, *** '***.
  5. *** **, **** : *** ****** *** ********* ********.*****://***.**********.***.***/**********_****/*********/****/***************_*****.***
  6. *** *, **** : *** **** *** ********* ********.*****://***.**********.***.***/**********_****/*********/****/********************.***
  7. *** *, **** : ***** *** ********* ********. *****://***.**********.***.***/**********_****/*********/****/********************.***
  8. *** *, **** : ** ********* ******** ****** ** *****, *** ******** **** **** *** ********** ******* *********** ** ** ******* ** *** *********. ** ***** ** **** *** *********** (*-***) ** *** ****** **** ******** ** *** **,****, ** ****** ******** ****** ***** ****.
  9. *** **, **** : *** ****** ******** *********** ***** ***** **** ** ****** ** ****** **. '*** ** ***** ********* *** **** ***.
  10. *** *, **** : *********** **** *** ****** **** ************ ** ****** **. '***.
  11. *** **, **** : ****** ******** *********** ********* ** **** ** ******.
  12. *** *, **** : *********** **** ****** **** ************ ** ****** ** '***, '***, '*** *** '***.

Xigduo XR - (2.5 mg/1000 mg; Tablet ER)

Dapagliflozin; Metformin hydrochloride Astrazeneca
2.5 mg/1000 mg; Tablet ER
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
Xigduo XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Yes
*** ****** ** ***. *** ****** ***** * **** ** ** ******* '***, '***, *** '***, *** *** *********. *** ****** **** ***** * **** *** ** ******* '***, '***, '***, *** '***. *** ****** *** ********* ********. ** ********* ******** ****** *** ***** (***** **** *.* **), *** ******** **** **** *** ********** ******* *********** ** ** ******* ** *** *********. ** ***** ** **** *** *********** (*-***) ** *** ****** **** ******** ** *** **,****, ** ****** ******** ****** ***** ****.
Xigduo XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
*** ****** **** *** **** ** *** **, **** **** *** *** ********* *** ********* *** ********* **** *** *** *********
**** *** ********* **** *** *** ********* *** ********* *** ********* *** ********* *** ********* *** *********
****** ******* **** **** *** ********* ******* **** **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** ******* **** **** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** \ *** -**- ******* ********* ******** ****** *** **, ****
**** ** \ ** -**- *** ********* ********* ******** ***** ***-**** ***********
****** ** \ ** **** **, **** ******* **** *** ****** **** ****
  1. *** *, **** : *** ****** ***** **** ** ** ******* '***, '*** *** *** (*** ******** ***** ****). *** ****** ***** ***** *** ** ****** '***
  2. *** **, **** : *** ****** *** ********* ********.*****://***.**********.***.***/**********_****/*********/****
  3. *** *, **** : ** ********* ******** ****** *** ***** (***** **** *.* **), *** ******** **** **** *** ********** ******* *********** ** ** ******* ** *** *********. ** ***** ** **** *** *********** (*-***) ** *** ****** **** ******** ** *** **,****, ** ****** ******** ****** ***** ****.
  4. *** **, **** : *** ****** ******** *********** ***** ***** **** ** ****** ** ****** **. '*** ** ***** ********* *** **** ***.
  5. *** *, **** : *********** **** *** ****** **** ************ ** ****** **. '***.
  6. *** **, **** : ****** ******** *********** ********* ** **** ** ******.
  7. *** *, **** : *********** **** ****** **** ************ ** ****** ** '***, '***, '*** *** '***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.